Bank of The West decreased its position in Aetna Inc. (NYSE:AET) by 0.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,624 shares of the company’s stock after selling 48 shares during the period. Bank of The West’s holdings in Aetna were worth $1,158,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of the company. FTB Advisors Inc. boosted its position in shares of Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock valued at $125,000 after buying an additional 97 shares in the last quarter. Signature Estate & Investment Advisors LLC acquired a new position in shares of Aetna during the first quarter valued at $133,000. Horan Capital Management acquired a new position in shares of Aetna during the first quarter valued at $157,000. Guardian Life Insurance Co. of America boosted its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares in the last quarter. Finally, Tompkins Financial Corp acquired a new position in shares of Aetna during the first quarter valued at $187,000. 91.72% of the stock is owned by institutional investors.
Shares of Aetna Inc. (AET) traded down 1.10% during midday trading on Friday, reaching $156.79. The company’s stock had a trading volume of 3,112,621 shares. Aetna Inc. has a one year low of $104.59 and a one year high of $161.69. The firm has a 50-day moving average of $153.22 and a 200-day moving average of $137.42. The stock has a market cap of $52.01 billion, a PE ratio of 47.82 and a beta of 0.54.
Aetna (NYSE:AET) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. The firm had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The business’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.21 EPS. On average, analysts forecast that Aetna Inc. will post $9.10 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Thursday, July 13th were paid a $0.50 dividend. The ex-dividend date was Tuesday, July 11th. This represents a $2.00 dividend on an annualized basis and a yield of 1.28%. Aetna’s dividend payout ratio (DPR) is presently 43.67%.
Several equities analysts have recently weighed in on AET shares. Cowen and Company set a $170.00 price target on shares of Aetna and gave the stock a “buy” rating in a research note on Saturday, May 27th. Credit Suisse Group reaffirmed a “buy” rating and set a $155.00 price target on shares of Aetna in a research note on Wednesday, May 17th. UBS AG reaffirmed a “buy” rating and set a $160.00 price target (up from $147.00) on shares of Aetna in a research note on Wednesday, May 17th. Bank of America Corporation reaffirmed a “buy” rating and set a $168.00 price target (up from $160.00) on shares of Aetna in a research note on Wednesday, May 17th. Finally, Stifel Nicolaus raised their price target on shares of Aetna from $150.00 to $158.00 and gave the stock a “buy” rating in a research note on Tuesday, May 16th. Eight equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $155.46.
In other news, EVP Margaret M. Mccarthy sold 27,028 shares of the company’s stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Mark T. Bertolini sold 103,547 shares of the company’s stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total value of $14,578,382.13. Following the transaction, the chairman now directly owns 659,888 shares in the company, valued at approximately $92,905,631.52. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
